GB202214614D0 - Compositions and methods for modulation of macrophage - Google Patents

Compositions and methods for modulation of macrophage

Info

Publication number
GB202214614D0
GB202214614D0 GBGB2214614.6A GB202214614A GB202214614D0 GB 202214614 D0 GB202214614 D0 GB 202214614D0 GB 202214614 A GB202214614 A GB 202214614A GB 202214614 D0 GB202214614 D0 GB 202214614D0
Authority
GB
United Kingdom
Prior art keywords
macrophage
modulation
compositions
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2214614.6A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Macomics Ltd
Original Assignee
Macomics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Macomics Ltd filed Critical Macomics Ltd
Priority to GBGB2214614.6A priority Critical patent/GB202214614D0/en
Publication of GB202214614D0 publication Critical patent/GB202214614D0/en
Priority to KR1020257014592A priority patent/KR20250096720A/ko
Priority to PCT/GB2023/050592 priority patent/WO2023170434A1/en
Priority to IL319958A priority patent/IL319958A/en
Priority to AU2023232991A priority patent/AU2023232991A1/en
Priority to CR20250172A priority patent/CR20250172A/es
Priority to EP23718793.5A priority patent/EP4476260A1/en
Priority to JP2025542435A priority patent/JP2025535192A/ja
Priority to CN202380079852.1A priority patent/CN120435496A/zh
Priority to US18/845,659 priority patent/US20250197491A1/en
Priority to MX2025003929A priority patent/MX2025003929A/es
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
GBGB2214614.6A 2022-03-11 2022-10-04 Compositions and methods for modulation of macrophage Ceased GB202214614D0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GBGB2214614.6A GB202214614D0 (en) 2022-10-04 2022-10-04 Compositions and methods for modulation of macrophage
US18/845,659 US20250197491A1 (en) 2022-03-11 2023-03-13 Compositions and methods for modulation of macrophage activity
AU2023232991A AU2023232991A1 (en) 2022-10-04 2023-03-13 Compositions and methods for modulation of macrophage activity
PCT/GB2023/050592 WO2023170434A1 (en) 2022-03-11 2023-03-13 Compositions and methods for modulation of macrophage activity
IL319958A IL319958A (en) 2022-10-04 2023-03-13 Compositions and methods for modulating macrophage activity
KR1020257014592A KR20250096720A (ko) 2022-10-04 2023-03-13 대식세포 활성을 조절하기 위한 조성물 및 방법
CR20250172A CR20250172A (es) 2022-10-04 2023-03-13 Composiciones y métodos para la modulación de la actividad de macrófagos
EP23718793.5A EP4476260A1 (en) 2022-03-11 2023-03-13 Compositions and methods for modulation of macrophage activity
JP2025542435A JP2025535192A (ja) 2022-10-04 2023-03-13 マクロファージ活性の調整のための組成物及び方法
CN202380079852.1A CN120435496A (zh) 2022-10-04 2023-03-13 调节巨噬细胞活性的组合物和方法
MX2025003929A MX2025003929A (es) 2022-10-04 2025-04-02 Composiciones y métodos para la modulación de la actividad de macrófagos

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2214614.6A GB202214614D0 (en) 2022-10-04 2022-10-04 Compositions and methods for modulation of macrophage

Publications (1)

Publication Number Publication Date
GB202214614D0 true GB202214614D0 (en) 2022-11-16

Family

ID=84000149

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2214614.6A Ceased GB202214614D0 (en) 2022-03-11 2022-10-04 Compositions and methods for modulation of macrophage

Country Status (8)

Country Link
JP (1) JP2025535192A (https=)
KR (1) KR20250096720A (https=)
CN (1) CN120435496A (https=)
AU (1) AU2023232991A1 (https=)
CR (1) CR20250172A (https=)
GB (1) GB202214614D0 (https=)
IL (1) IL319958A (https=)
MX (1) MX2025003929A (https=)

Also Published As

Publication number Publication date
JP2025535192A (ja) 2025-10-22
MX2025003929A (es) 2025-05-02
CR20250172A (es) 2025-09-04
IL319958A (en) 2025-05-01
AU2023232991A1 (en) 2025-04-10
CN120435496A (zh) 2025-08-05
KR20250096720A (ko) 2025-06-27

Similar Documents

Publication Publication Date Title
IL309952A (en) Compositions and methods for treating melanoma
IL308041A (en) Collagen compositions and methods of using them
IL307625A (en) Compounds and methods for modulating pnpla3 expression
IL304159A (en) A preparation containing bl-8040
IL314824A (en) Combination formulation of sedazuridine
LT4192814T (lt) Transgliutaminazės inhibitoriai
EP4143303A4 (en) COMPOSITIONS AND METHODS FOR PROMOTING MYELINIZATION
GB202214614D0 (en) Compositions and methods for modulation of macrophage
IL315862A (en) Angiotensinogen modulators and methods of using them
GB202314084D0 (en) Compositions and methods for modulation of macrophage activity
GB202203384D0 (en) Compositions and Methods for Modulation of Macrophage Activity
GB202314086D0 (en) Compositions and method for modulation of macrophage activity
CA3269723A1 (en) Compositions and methods for modulation of macrophage activity
HK40119976A (en) Compositions and methods for modulation of macrophage activity
CA3261629A1 (en) COMPOSITIONS AND METHODS OF USE FOR DEGREASING EQUIPMENT
IL309077A (en) Transglutaminase inhibitors
CA3269451A1 (en) Compositions and methods for modulation of cftr
CA3286796A1 (en) Compositions for modulation of il-2 and methods thereof
AU2024238641A1 (en) Compositions for modulation of il-2 and methods thereof
IL326294A (en) Epilepsy compositions and methods of use
GB202313643D0 (en) Serping1-sarna compositions and methods of use
GB202310868D0 (en) compositions and methods of use
HK40117615A (en) Compositions and methods for treatment of epilepsies
HK40111951A (en) Compositions and methods for treatment of melanoma
CA3292686A1 (en) Fiber-based compositions and methods for the modulation of the gut mircobiome

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)